Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure. | Biologics;6: 191-9, 2012. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure.

Kekow, Joern; Mueller-Ladner, Ulf; Schulze-Koops, Hendrik.

Afiliação

Kekow J; Clinic of Rheumatology and Orthopedics, Otto-von-Guericke University of Magdeburg, Vogelsang-Gommern.

Biologics ; 6: 191-9, 2012.

Article em En | MEDLINE | ID: mdl-22848150

Palavras-chave

anti-cyclic citrullinated peptide antibodies; rheumatoid arthritis; rheumatoid factor; rituximab

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biologics Ano de publicação: 2012 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biologics Ano de publicação: 2012 Tipo de documento: Article